Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.240
+0.340 (8.72%)
At close: Jun 26, 2026, 4:00 PM EDT
4.100
-0.140 (-3.30%)
After-hours: Jun 26, 2026, 7:48 PM EDT
Orchestra BioMed Holdings Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Orchestra BioMed Holdings stock have an average target of 12.83, with a low estimate of 9.00 and a high estimate of 20. The average target predicts an increase of 202.59% from the current stock price of 4.24.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 19, 2026.
Analyst Ratings
The average analyst rating for Orchestra BioMed Holdings stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst BTIG No rating | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 15, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $12 → $10 | Buy | Reiterates | $12 → $10 | +135.85% | May 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +135.85% | May 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 | Buy | Maintains | $9 | +112.26% | May 13, 2026 |
| Barclays | Barclays | Buy Reiterates $12 → $13 | Buy | Reiterates | $12 → $13 | +206.60% | May 13, 2026 |
Financial Forecast
Revenue This Year
476.33K
from 33.48M
Decreased by -98.58%
Revenue Next Year
661.14K
from 476.33K
Increased by 38.80%
EPS This Year
-1.50
from -1.11
EPS Next Year
-1.46
from -1.50
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 575,000 | 1.4M | |
| Avg | 476,330 | 661,140 | |
| Low | 400,000 | 400,000 |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -98.3% | 186.4% | |
| Avg | -98.6% | 38.8% | |
| Low | -98.8% | -16.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.30 | -1.10 | |
| Avg | -1.50 | -1.46 | |
| Low | -1.60 | -1.81 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.